Further mechanistic findings suggested that OTUD1 may inhibit the SOX9/SPP1 axis by delaying the nuclear translocation of YAP1, thus reversing the resistance of NSCLC cells to erlotinib. This evidence concerns the gene SOX9 and non-small cell lung carcinoma.